East Boston resident running for cancer research
Running in the Boston Marathon to raise
money for Dana-Farber Cancer Institute
|
On April 17, East Boston resident Aiko Sogabe
is running to conquer cancer as a member of the Dana-Farber Marathon
Challenge team in the 121st Boston Marathon®.
Along with more
than 500 Dana-Farber Marathon Challenge teammates from across the United
States and around the world, they will run Massachusetts’ historic
marathon route from Hopkinton to Boston to collectively raise $5 million
for cancer research at Dana-Farber Cancer Institute.
This year marks the 28th annual running of the Dana-Farber Marathon Challenge
(DFMC) team. One hundred percent of the money raised by the Dana-Farber Marathon
Challenge goes to Dana-Farber’s Claudia Adams Barr Program in Innovative Basic
Cancer Research, which supports promising scientific research in its earliest
stages. The Dana-Farber Marathon Challenge has raised more than $80 million for
the Barr Program to date.
In 1990, Dana-Farber was among the
first charity organizations to be recognized by the Boston Athletic Association
(B.A.A), which organizes the Boston Marathon. The Dana-Farber Marathon Challenge
team offers its members extensive fundraising support, training guidance from
1976 Boston Marathon men’s champion Jack Fultz, and team training runs, plus
volunteer opportunities for non-runners. Dana-Farber Marathon Challenge runners
who are not time-qualified for the Boston Marathon receive an invitational entry
into the race. |
|
Dana-Farber Marathon Challenge runners include
cancer survivors and patients, and family and friends of those who have been
affected by cancer. Each team member must fulfill a basic fundraising
commitment:
Invitational runners receive their entry from Dana-Farber and
have a fundraising commitment of $5,000.
Own entry runners join the DFMC team
after obtaining their own race entry and have a fundraising commitment of
$4,000.
A cornerstone of the Dana-Farber Marathon Challenge is
its Partner Program. Each year, approximately 50 current and former pediatric
cancer patients of Dana-Farber’s Jimmy Fund Clinic are paired with DFMC runners
as “Patient Partners.” For the young patients, their partnerships with the
runners provide a unique and friendly focus outside their illnesses. Another two
dozen Patient Partner Program families are paired with runners through the
“In-Memory Program” in remembrance of their children’s brave struggle with the
disease.
To contribute to the Dana-Farber Marathon Challenge or
support a runner, visit RunDFMC.org or contact the Dana-Farber Marathon
Challenge office at (617) 632-1970 or dfmc@dfci.harvard.edu. Follow DFMC on
Facebook: www.facebook/marathonchallenge. On Twitter: #RunDFMC
Dana-Farber’s Claudia Adams Barr Program
Since its inception in 1990, the
Dana-Farber Marathon Challenge has raised more than $80 million for the Barr
Program. Dana-Farber Trustees J. Wayne and Delores Barr Weaver founded the Barr
Program in 1987 to honor Mrs. Weaver’s mother, Claudia Adams Barr, who lost her
battle with cancer 30 years earlier.
This year marks the 28th annual running of the Dana-Farber Marathon Challenge
(DFMC) team. One hundred percent of the money raised by the Dana-Farber Marathon
Challenge goes to Dana-Farber’s Claudia Adams Barr Program in Innovative Basic
Cancer Research, which supports promising scientific research in its earliest
stages. The Dana-Farber Marathon Challenge has raised more than $80 million for
the Barr Program to date.
In 1990, Dana-Farber was among the
first charity organizations to be recognized by the Boston Athletic Association
(B.A.A), which organizes the Boston Marathon. The Dana-Farber Marathon Challenge
team offers its members extensive fundraising support, training guidance from
1976 Boston Marathon men’s champion Jack Fultz, and team training runs, plus
volunteer opportunities for non-runners. Dana-Farber Marathon Challenge runners
who are not time-qualified for the Boston Marathon receive an invitational entry
into the race.
From achieving the first remissions in cancer with chemotherapy
in 1948, to developing the very latest new therapies, Dana-Farber Cancer
Institute is one of the world’s leading centers of cancer research and
treatment. It is the only center ranked in the top 4 of U.S. News and World
Report’s Best Hospitals for both adult and pediatric cancer care.
Dana-Farber sits at the center of a wide range of collaborative efforts to
reduce the burden of cancer through scientific inquiry, clinical care,
education, community engagement, and advocacy. Dana-Farber/Brigham and Women’s
Cancer Center provides the latest in cancer care for adults; Dana-Farber/Boston
Children's Cancer and Blood Disorders Center for children. The
Dana-Farber/Harvard Cancer Center unites the cancer research efforts of five
Harvard academic medical centers and two graduate schools, while Dana-Farber
Community Cancer Care provides high quality cancer treatment in communities
outside Boston’s Longwood Medical Area.
|
|